Today’s post comes courtesy of guest guru and Clinical Trials Guru Producer, Darshan Kulkarni of Kulkarni Law Firm. Darshan and I get into a viewer question in regards to a PI transferring his studies from one research company to another (perhaps his or her own company). As Darshan is a legal expert on these matters, I decided to let him get into some of the complications that one can run into under this scenario.
Research clinics this video is especially for you. In clinical trials, as you probably know, there are costs such as transportation fees that you have to pay upfront for. Please do not forget to regularly invoice for these costs and negotiate them in your budgets. Another cost that can sneak up on you are the sub-studies. Often these sub-studies do not compensate the site or the study participant very much, but still require a lot of work. Make sure you either negotiate for these costs or be careful about doing them at all. These and more topics are discussed in this video. Let me know your thoughts.
Today’s video is in regards to clinical trial budgets, and your power as a research clinic that has performed well on an existing study, to renegotiate the budget for better terms. In particular, the screen fail reimbursement ratio should be examined, and if appropriate, renegotiated for better terms. In this video, I explain this and more topics in greater detail. Let me know if you found this helpful!
Today I answered a viewer question regarding budgeting and negotiation of Clinical Trial Agreements (CTA’s). These are essentially the contracts that each research clinic must have in place in order to determine and spell out how the research clinic will be paid, how much, and under what terms. Today’s video answers a few specific questions relating to negotiating these CTA’s. I hope it provides some value.
LoveRela
SFVapor
Delicate
aselvers
mortgage
nyoro99
heyo
JByrnePM
IsamuHar
Cartridg
